Axogen, Inc. (AXGN)

NasdaqCM • Currently up 1.27 (+2.61%) in today's trading session

1 member of Congress has disclosed 4 trades in Axogen, Inc. (AXGN) via STOCK Act filings. The most recent disclosure was a sale by Donna E. Shalala on 24 June 2019. Aggregate disclosed activity totals roughly $16K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

Axogen, Inc. is currently trading at $50.02, positioned at 90% of its 52-week range ($23.00 – $52.91).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$50.02
24h Change
+1.27 (+2.61%)
52 Week Range
$23.00–$52.91
View on NASDAQ

Axogen, Inc. Price History and Technical Analysis

Congressional Trading Activity for AXGN

Select to highlight on chart
4 transactions
Compliance: 50%
Donna E. Shalala24 Jun 201927 Apr 2020SaleStock$1,001 - $15,000N/A
Donna E. Shalala24 Jun 201921 Jul 2020SaleStock$1,001 - $15,000N/A
Donna E. Shalala16 Apr 201927 Apr 2020PurchaseStock$1,001 - $15,000N/A
Donna E. Shalala16 Apr 201921 Jul 2020PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$2.99B

Volume

1.67M

Beta

1.17

P/E Ratio

131.63

Fundamentals

EPS

$0.38

Div. Yield

-

Open

$48.55

Day Range

$48.14 – $50.13

Company Information

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ · USD
Country
US
CEO
Michael D. Dale
IPO Date
1986-12-17
Website
www.axogeninc.com

AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance...

Earnings

Next Report

Q4 2026

23 Feb

EPS Est.

$0.15

Rev. Est.

$83.3M

Days Until

106

Recent Quarters

Q3 202628 Oct
EPS$0.21
Beat 59.9%
Q2 202629 Jul
EPS$0.12
Miss 1.1%
Q1 202628 Apr
EPS$0.07
Miss 41.7%
Q4 202524 Feb
EPS$0.07
Miss 21.2%
Q3 202529 Oct
EPS$0.12
Beat 33.3%
Q2 20255 Aug
EPS$0.12
Beat 100.0%
Q1 20258 May
EPS$-0.02
Miss 100.0%
Q4 202425 Feb
EPS$0.08
Beat 100.0%
Q3 20247 Nov
EPS$0.07
Beat 1066.7%
Q2 20248 Aug
EPS$0.05
Beat 200.0%
Q1 20242 May
EPS$-0.06
Beat 40.0%
Q4 20235 Mar
EPS$-0.06
Beat 33.3%
Q3 20237 Nov
EPS$0.01
Beat 112.5%
Q2 20237 Aug
EPS$-0.03
Beat 80.0%
Q1 20239 May
EPS$-0.10
Beat 33.3%
Q4 202214 Mar
EPS$-0.03
Beat 70.0%
Q3 20228 Nov
EPS$-0.01
Beat 93.3%
Q2 20223 Aug
EPS$-0.06
Beat 60.0%
Q1 20224 May
EPS$-0.20
Miss 17.6%
Q4 202122 Feb
EPS$-0.08
Beat 38.5%
Q3 20213 Nov
EPS$-0.09
Beat 25.0%
Q2 20214 Aug
EPS$-0.09
Beat 25.0%
Q1 20215 May
EPS$-0.08
Beat 52.9%
Q4 202022 Feb
EPS$-0.08
Beat 27.3%
Q3 202029 Oct
EPS$0.04
Beat 130.8%
Q2 20205 Aug
EPS$-0.15
Beat 40.0%
Q1 20206 May
EPS$-0.19
Beat 24.0%
Q4 201924 Feb
EPS$-0.10
Miss 25.0%
Q3 20196 Nov
EPS$-0.07
Beat 30.0%
Q2 20196 Aug
EPS$-0.10
Beat 23.1%
Q1 20198 May
EPS$-0.15
Miss 7.1%
Q4 201826 Feb
EPS$-0.09
Miss 80.0%
Q3 201829 Oct
EPS$-0.05
Beat 0.0%
Q2 20181 Aug
EPS$-0.09
Miss 80.0%
Q1 201830 Apr
EPS$-0.11
Beat 0.0%
Q4 201728 Feb
EPS$-0.07
Beat 22.2%
Q3 20171 Nov
EPS$-0.06
Beat 25.0%
Q2 20172 Aug
EPS$-0.06
Beat 25.0%
Q1 20174 May
EPS$-0.11
Miss 10.0%
Q4 201622 Feb
EPS$-0.10
Beat 0.0%
Q3 20162 Nov
EPS$-0.08
Beat 11.1%
Q2 20163 Aug
EPS$-0.09
Beat 25.0%
Q1 20164 May
EPS$-0.12
Beat 7.7%
Q4 201529 Feb
EPS$-0.12
Miss 9.1%
Q3 20155 Nov
EPS$-0.11
Beat 8.3%
Q2 20156 Aug
EPS$-0.13
Beat 13.3%
Q1 20155 May
EPS$-0.16
Beat 5.9%
Q4 20145 Mar
EPS$-0.36
Miss 100.0%
Q3 201413 Nov
EPS$-0.19
Beat 20.8%
Q2 20144 Aug
EPS$-0.21
Beat 12.5%
Q1 201430 Apr
EPS$-0.24
Beat 7.7%
Q4 20136 Mar
EPS$-0.24
Beat 0.0%
Q3 201330 Oct
EPS$-0.25
Miss 25.0%
Q2 201314 Aug
EPS$-0.31
Miss 10.7%
Q1 201330 Apr
EPS$-0.31
Miss 19.2%
Q4 201212 Mar
EPS$-0.36
Miss 56.5%
Q3 20127 Nov
EPS$-0.20
Miss 11.1%
Q2 201214 Aug
EPS$-0.16
Beat 11.1%
Q1 201214 May
EPS$-0.19
Beat 0.0%
Q4 201115 Mar
EPS$-0.19
Q4 201114 Mar
EPS$-0.58
Miss 163.6%
Q2 201111 Aug
EPS$0.21
Q1 201117 May
EPS$0.75
Q4 201030 Mar
EPS$-0.09
Q3 201015 Nov
EPS$-0.39
Q2 201016 Aug
EPS$-0.05
Q1 201017 May
EPS$-0.06
Q4 200931 Mar
EPS$3.53
Q3 200916 Nov
EPS$-0.03
Q2 200913 Aug
EPS$0.03
Q1 200914 May
EPS$-0.03
Q4 200831 Mar
EPS$-0.03
Q3 200819 Nov
EPS$-0.14
Q2 200814 Aug
EPS$-0.04
Q1 200815 May
EPS$-0.04
Q1 200811 Apr
EPS$-0.00
Q3 200714 Nov
EPS$-0.11
Q2 200713 Aug
EPS$-0.04
Q1 200715 May
EPS$-0.03
Q4 200630 Mar
EPS$-0.04
Q3 200614 Nov
EPS$-0.01
Q2 200614 Aug
EPS$-0.03
Q1 200615 May
EPS$-0.01
Q4 200520 Mar
EPS$0.03
Q3 200514 Nov
EPS$0.00
Q2 200515 Aug
EPS$-0.02
Q1 200513 May
EPS$-0.14
Q1 200515 Apr
EPS$0.25
Q3 200415 Nov
EPS$0.28
Q2 200416 Aug
EPS$0.00
Q1 200412 May
EPS$0.02
Q4 200329 Mar
EPS$-0.04
Q3 200318 Nov
EPS$-0.09
Q2 200312 Aug
EPS$-0.11
Q1 200314 May
EPS$-0.09
Q1 200314 Apr
EPS$-0.17
Q3 200214 Nov
EPS$-0.09
Q2 200214 Aug
EPS$-0.19
Q1 200215 May
EPS$-0.20
Q3 200114 Nov
EPS$-0.30
Q2 200128 Sept
EPS$0.81
Q1 200115 May
EPS$-0.14
Q4 200014 Feb
EPS$-0.18
Q3 200014 Nov
EPS$-0.15
Q2 200028 Sept
EPS$-0.21
Q1 200015 May
EPS$-0.17
Q4 199914 Feb
EPS$-0.21
Q3 199912 Nov
EPS$-0.16
Q2 199928 Sept
EPS$-0.13
Q1 199917 May
EPS$-0.08
Q4 199816 Feb
EPS$-0.17
Q3 199813 Nov
EPS$-0.04
Q2 199828 Sept
EPS$-0.06
Q1 199815 May
EPS$-0.07
Q3 199713 Nov
EPS$0.05
Q2 199726 Sept
EPS$-0.16
Q1 199715 May
EPS$-0.38
Q4 199614 Feb
EPS$-0.07
Q3 199614 Nov
EPS$0.01
Q2 199630 Sept
EPS$-0.01
Q1 199615 May
EPS$0.03
Q4 199514 Feb
EPS$-0.17
Q3 199514 Nov
EPS$-0.03
Q2 199528 Sept
EPS$-0.03
Q1 199512 May
EPS$0.05
Q4 19941 Feb
EPS$0.01
Miss 88.9%
Q3 199431 Oct
EPS$0.02
Miss 80.0%
Q2 19947 Sept
EPS$0.03
Miss 40.0%
Q1 199426 Apr
EPS$0.01
Q4 199326 Jan
EPS$0.07
Miss 22.2%
Q3 199331 Dec
EPS$0.07
Q1 199330 Jun
EPS$0.05
Q4 199231 Mar
EPS$0.06
Q3 199231 Dec
EPS$0.04
Q2 199230 Sept
EPS$0.07
Q1 199230 Jun
EPS$0.07
Q4 199131 Mar
EPS$0.05
Q3 199131 Dec
EPS$0.08
Q2 199130 Sept
EPS$0.08
Q1 199130 Jun
EPS$0.05
Q4 199031 Mar
EPS$0.08
Q3 199031 Dec
EPS$0.08
Q2 199030 Sept
EPS$0.07
Q1 199030 Jun
EPS$-0.73
Q4 198931 Mar
EPS$-0.05
Q3 198931 Dec
EPS$0.02
Q2 198930 Sept
EPS$0.07
Q1 198930 Jun
EPS$0.03
Q4 198831 Mar
EPS$0.04
Q3 198831 Dec
EPS$0.07
Q2 198830 Sept
EPS$0.06
Q1 198830 Jun
EPS$0.10
Q4 198731 Mar
EPS$0.06
Q3 198731 Dec
EPS$0.06
Q2 198730 Sept
EPS$0.06
Q1 198730 Jun
EPS$0.06
Q4 198631 Mar
EPS$0.05
Q3 198631 Dec
EPS$0.05
Q2 198630 Sept
EPS$0.05

2 politicians traded within 30 days

Dividends

Dividend History

27 Jan 2010
Amount $1.0000
23 Feb 2005
Amount $0.0600
10 Jul 1992
Amount $0.0417

Stock Splits

Split History

11 Jul 1994Stock Split
Ratio21:20
12 Jul 1993Stock Split
Ratio21:20
10 Jul 1992Stock Split
Ratio21:20

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about AXGN

Which members of Congress have traded AXGN?
1 member of Congress has disclosed 4 trade in Axogen, Inc. (AXGN) under the STOCK Act: Donna E. Shalala.
When was AXGN most recently disclosed by Congress?
The most recent AXGN disclosure was a sale by Donna E. Shalala on 24 June 2019.
What is the total disclosed congressional trading volume for AXGN?
Members of Congress have disclosed approximately $16K in AXGN purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in AXGN?
This AXGN page updates as soon as new STOCK Act disclosures are filed for Axogen, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.